Orbai, Ana-Maria http://orcid.org/0000-0001-8644-8567
Chakravarty, Soumya D. http://orcid.org/0000-0001-7957-838X
You, Yin
Shawi, May http://orcid.org/0000-0001-6005-3938
Yang, Ya-Wen
Merola, Joseph F. http://orcid.org/0000-0001-6514-4353
Clinical trials referenced in this document:
Documents that mention this clinical trial
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials
https://doi.org/10.1007/s13555-024-01123-1
Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis
https://doi.org/10.1007/s13555-023-01012-z
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
https://doi.org/10.1007/s40257-023-00816-1
Documents that mention this clinical trial
Old and new treatment targets in axial spondyloarthritis
https://doi.org/10.1136/rmdopen-2015-000054
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study
https://doi.org/10.1007/s40257-020-00555-7
Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis
https://doi.org/10.1007/s13555-023-01012-z
Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 18 July 2023
Accepted: 10 August 2023
First Online: 15 September 2023
Declarations
:
: Ana-Maria Orbai has received grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Horizon, Novartis, and Janssen; and consulting fees from Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Soumya D Chakravarty is an employee of Janssen Scientific Affairs, LLC and owns stock or stock options in Johnson & Johnson. Yin You is an employee of Janssen Research & Development, LLC. Ya-Wen Yang is an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. May Shawi is an employee of Janssen Research & Development, LLC, and owns stock in Johnson & Johnson. Joseph F Merola is a consultant and/or investigator for AbbVie, Amgen, Biogen, Bristol Myers Squibb, Dermavant, Eli Lilly, Incyte, Janssen, Leo Pharma, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, and UCB.
: These studies were conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practices. The governing ethical bodies for each of the participating sites approved the VOYAGE-1 and -2 study protocols, and all patients provided written informed consent.